Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms 2024-08-29 20:42
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future 2024-03-28 22:46
Viva Biotech Secures Approximately US$ 210 Million Funding 2023-11-20 20:04
Viva Biotech (1873.HK) Announces 2023 Interim Results：Solid Growth in Main Business, Significant Rebound in Profitability 2023-08-29 22:38
Latest Updates of 7 Viva's Portfolio Companies 2023-07-28 19:31
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs 2023-07-20 19:15
Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis 2023-07-18 15:00
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million 2023-06-16 14:20
Viva Biotech's Recent Conferences & Events Review 2023-05-05 19:58
Viva Biotech Announced 2022 Annual Results: 2023-03-31 00:25
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies 2022-12-02 18:23
Viva Biotech Announced 2022 Interim Results 2022-08-29 23:55
Viva Biotech Successfully Held The 3rd Annual Partnership Summit 2022-06-23 20:30
Portfolio Highlights: Clinical and Financing Updates of Anji, AIxplorerBio, Domain, VivaVision, ArrePath, QurAlis and Apeiron 2022-05-26 23:53
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7% 2022-03-29 01:01
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7% 2022-03-29 00:49
Joint Fight Against COVID-19, Viva Biotech Contributes to the Production of the Oral COVID-19 Antiviral Medication and Virus Tests 2022-03-18 17:47
Viva Biotech Announced 2021 Interim Results 2021-08-31 01:32
Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci 2021-06-16 10:14
Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology 2021-05-10 18:21
1 2